Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders
US10195435B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Nov 10, 2016 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Nov 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36175
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.